Johnson Controls Invests In Phylagen For Technology On Microbiome Optimization

Johnson Controls International PLC JCI has signed a joint development agreement with Phylagen, a biotechnology company in microbiome optimization of indoor environments.
The agreement includes a strategic investment in Phylagen. The financial terms of the deal were not disclosed.
Through this agreement, the companies develop cutting-edge technology that leverages the science of building microbiomes to improve the future of healthy buildings.
Price Action: JCI shares traded higher by 1.87% at $74.18 on the last check Thursday.